Hematologist Libby joins Clinical Research Division

Edward Libby aims to advance the diagnosis, treatment of lymphoma, plasma cell diseases
Dr. Edward Libby
Dr. Edward Libby focuses on the diagnosis and treatment of lymphoma and plasma cell diseases. Photo by Linsey Battan

Dr. Edward Libby joined the myeloma and lymphoma teams in the Clinical Research Division this summer.

Libby, whose primary appointment is at the University of Washington as an associate professor of internal medicine in the Medical Oncology Division, will plan and implement clinical trials to advance the diagnosis and treatment of patients with lymphoma and plasma cell diseases like multiple myeloma, Waldenstroms macroglobulinemia and amyloidosis.

“The opportunity to work in a world-class research center surrounded by first-rate scientists and clinicians was irresistible,” said Libby of his decision to work for the Center. “Also, there is a large population in the Northwest from which to draw on for scientific research, making clinical studies far easier to accomplish in a shorter time.”

He last worked as an attending physician at the University of New Mexico Hospital and Lovelace Medical Center in Albuquerque and as an associate professor in the University of New Mexico Health Sciences Center’s Division of Hematology and Oncology. Libby was twice ranked a “Top Doc of Albuquerque.” He received his medical degree from the University of Texas Health Sciences Center at Houston.

“Ed is a very personable, highly motivated hematologist with a wide experience in the treatment of complex oncology patients,” said Dr. Bill Bensinger of Clinical’s Autologous Transplant Program. “He is collegial and very interested in developing research studies that improve patient care.”

Help Us Eliminate Cancer

Every dollar counts. Please support lifesaving research today.